论文部分内容阅读
目的:评价奥扎格雷用于治疗短暂性脑缺血患者的临床疗效。方法:选取2010年1月—2012年1月间神经内科门诊就诊并诊断为短暂性脑缺血的患者100例,将其分为对照组患者和观察组患者,每组50例;对照组患者给予基础治疗方法治疗,观察组患者在对照组基础方法治疗上加用奥扎格雷治疗,比较两组患者治疗后发作次数和康复时间。结果:观察组患者治疗后短暂性脑缺血发作次数为1.5次/d明显少于对照组为4.5次/d(P<0.05);观察组患者治疗后的康复时间为(14±1.5)d明显短于对照组为(20±2.5)d(P<0.05)。结论:临床上治疗短暂性脑缺血的患者,在常规治疗方法的基础上加用奥扎格雷治疗优于常规治疗方法,提高了治疗的有效率,缩短了患者的住院时间。
Objective: To evaluate the clinical efficacy of ozagrel in the treatment of patients with transient cerebral ischemia. Methods: A total of 100 patients diagnosed as transient ischemic attack from January 2010 to January 2012 in our department were divided into control group and observation group, 50 cases in each group. Patients in control group The patients in the observation group were treated with ozagrel on the basis of the treatment of the control group. The number of attacks and the recovery time were compared between the two groups after treatment. Results: The number of transient ischemic attack in observation group was significantly lower than that in control group after 1.5 times / d (P <0.05), while the recovery time in observation group was (14 ± 1.5) d Significantly shorter than the control group (20 ± 2.5) d (P <0.05). Conclusion: The clinical treatment of patients with transient ischemic injury, based on the conventional treatment method plus Ozagrel therapy is superior to conventional treatment methods, improve the efficiency of treatment and shorten the hospital stay of patients.